Skip to content
Screener

Biohaven BHVN Accounts Payable

Accounts Payable at other companies

Eli Lilly logo
Eli LillyLLY
$6.11B+50.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$43.67M+38.3%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$2.8M-12.0%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$17.75M+45.1%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$7.15M+28.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$3.35M+41.5%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.19B+45.4%
Enterprise value$2.2B+35.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001935979-26-000045
Line itemMarch 31, 2026December 31, 2025
Total assets$466,406$451,447
Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable$10,422$11,643
Accrued expenses and other current liabilities41,653104,291
Total current liabilities52,075115,934
Non-current operating lease liability38,36339,958
Notes payable241,912238,900

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's accounts payable?
Biohaven (BHVN) reported accounts payable of $10.42M in Q1 2026.
How has Biohaven's accounts payable changed year-over-year?
Biohaven's accounts payable decreased by 45.6% year-over-year, from $19.14M to $10.42M.
What is the long-term trend for Biohaven's accounts payable?
Over 4 years (2021 to 2025), Biohaven's accounts payable has grown at a 87.1% compound annual growth rate (CAGR), from $5.54M to $67.9M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Biohaven's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude